Biomedical HIV care has expanded options to stop the spread of the virus. This track will focus on PrEP (Pre-Exposure Prophylaxis), PEP (Post Exposure Prophylaxis), Treatment as Prevention (TasP) and START (Strategic Timing of Anti-Retroviral Treatment). It will discuss the latest innovations, programs and targets in order to scale up biomedical HIV prevention programs at your agency, city or state.
Today in the field of HIV, there are new and exciting forms of medication delivery being studied and evaluated for efficacy in the forms of long-acting implants and injectables. It is imperative that equitable education and awareness regarding new research for HIV and associated illnesses reach highly-impacted populations. Through the federal Ending the HIV Epidemic initiative, funding has been set aside for the Centers for AIDS Research (CFARs) to help achieve equitable community preparation for new research.
Gay men continue to have the highest rate of new infections and the largest number of people living with HIV in America. This track will focus on gay men, particularly gay men of color. What are the opportunities, challenges and innovations in HIV prevention, services, outreach, housing, treatment and healthcare?
PrEP is an important piece to End the Epidemic. Program implementation is an important skill to ensure successful PrEP navigation and Client services. Intentionally demonstrate and offer culturally responsive approaches to engage, navigate and retain vulnerable populations on PrEP. The track will focus on community-based experiences of PrEP engagement, navigation and retention.
Elimination of viral hepatitis is possible in our lifetimes, but not without a comprehensive and integrated approach. This track will focus on hepatitis elimination strategies and how a syndemic approach must be taken that incorporates an end to the HIV epidemic, overdose prevention, and other public health efforts. Additional barriers to advancing hepatitis elimination will also be examined, including criminalization of hepatitis and drug use, treatment access issues in correctional settings and with public and private insurers, and health inequities.
In this track we address, what are the challenges for Heterosexual men? How do we reach them? How engage them in conversations and decision making as we move forward to ETE? What are their needs?
What skills are needed to be an effective leader in the fight to end HIV? This skills-building track focuses on leadership within CBOs, health centers, activist groups, and the government. Leaders are also getting old, when is it time to leave? How do you manage transition? How should our movement identify, nurture and grow the next generation? What can our movement do to support existing leaders?
This track will focus on city, county, state and federal policies. It will examine policies that impact HIV prevention, healthcare, treatment, housing, research, and syringe exchange. It will look at federal programs like the Affordable Care Act, Medicaid expansion, HOPWA and the Ryan White Care Act. What are the advocacy strategies to stop the criminalization of HIV transmission, increase state and federal appropriations, fund HIV research, prevention, healthcare, and to end the epidemic?
This track will focus on what it means to live with HIV in America. PLWH are not a monolithic community and should not be treated like they are all the same. Stigma will be a major focus. This track will also cover aging, empowerment, self-determination, the criminal justice system, advocacy, and building a PLWH movement. The main focus will be for consumers; however, the conference also hopes to have a dialogue between providers and people living with the virus.
The focus of this track will be on the U.S. South, particularly through the lenses of the administrations Ending the HIV Epidemic plan; addressing stigma and structural barriers (i.e., lack of housing, food, transportation, health care, mental health services, etc.); the critical role of persons with lived experience having meaningful involvement; and the role of advocacy in shaping policies that impact services on the ground.
The nation’s opioid epidemic is significantly intertwined with the increasing rates of HIV and viral hepatitis in our communities. The conference seeks proposals that address prevention services for people injecting drugs and developing local plans to coordinate prevention, rehabilitation and treatment services.
This track focuses on the needs of transgender and gender nonconforming people and their lived experiences. Workshops will focus on ways organizations can include gender-affirming care to transgender and gender nonconforming people. Specific subjects include decriminalization, PrEP for transwomen and transmen, and systematic approaches for transwomen of color. Special sessions will focus on specific populations under the transgender umbrella, particularly in the South.
Trauma Informed Care (TIC) is an organizational structure and treatment framework that involves understanding, recognizing, and responding to the effects of all types of trauma. TIC also emphasizes physical, psychological and emotional safety for both consumers and providers, and helps survivors rebuild a sense of control and empowerment. HIV, racism, sexism, homophobia, transphobia and xenophobia are all possible causes of trauma. USCA seeks abstracts that address how trauma informed care ultimately results in increased retention in HIV care.
Often in the epidemic Transmen are overlooked as a “low-risk” population and are excluded from research studies and strategic ETE conversations. This track will focus on care, access, inclusion, retention and advocacy for trans men. This track will also focus on leadership skills building and empowerment for trans men to improve health outcomes. Is your organization and community ready for a Tran Man in leadership?
Undetectable = Untransmittable (U=U) is based on the science that demonstrates people with HIV who are on treatment and have an undetectable viral load do not sexually transmit HIV. This pathway will focus on how the U=U message can be utilized to move us toward universal access to treatment for all. Abstracts that address the following topics will be strongly considered: (1) Stigma reduction (2) Racial Justice and U=U – (3) Public health argument for U=U and universal access – The Third U – using U=U messages as a clarion call for universal access to treatment and improving the number of people in the U.S. who are not in care, on treatment, and ultimately, virally suppressed. (4) U=U for Providers (5) V does NOT equal V – Viral load does not equal Value. If people with HIV are unable to achieve an undetectable viral load, they are as valuable as those who do. Treatment is also an individual choice and some people may opt against it. How can we ensure that people who are not undetectable are not left out and that there is not more stigma against them? And what other tools and strategies should we be employing to ensure that we continue to focus on reducing new infections and caring for all people with HIV?
What are the latest advances in services for women living with HIV or at risk for HIV? What are the opportunities, challenges and innovations in HIV prevention, treatment, housing, and healthcare? What are the effective trauma-informed care and HIV-related violence prevention programs? Is your agency open to cis and trans women directors, clients or board members?
We are seeking abstracts that are focused on developing the skills of our next generation of leaders. Topics include: HIV and public health literacy, advocacy, leadership development, and integrating youth-specific messaging in local, state and national HIV/AIDS programs.